Physician profile
Daniel Ng
NPI 1932696432
$2,160.50
in general payments reported to CMS, 2019-2025
19 companies · $223 in 2025
The $223 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.84 · 2021: $375 · 2022: $419 · 2023: $679 · 2024: $421 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,322.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $851.02 | 2021-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $389.10 | 2023-2025 | |
| Kestra Medical Technology Services, INC. | $157.15 | 2023-2024 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $124.25 | 2025 | Amvuttra |
| Chiesi USA, INC. | $82.03 | 2022-2023 | Kengreal |
| Pfizer INC. | $80.23 | 2021-2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $71.63 | 2023 | Arcalyst |
| Irhythm Technologies, INC. | $60.10 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Astrazeneca Pharmaceuticals Lp | $56.27 | 2023-2024 | Farxiga |
| Akcea Therapeutics, INC. | $43.84 | 2019 | |
| Janssen Pharmaceuticals, INC | $39.84 | 2023-2024 | Xarelto |
| Philips North America LLC | $38.03 | 2023 | |
| Medtronic, INC. | $32.20 | 2023 | Azure Xt Dr Mri Surescan |
| Lantheus Medical Imaging, INC. | $28.07 | 2024 | |
| Getinge USA Sales, LLC | $25.82 | 2023 | Cardiosave Hybrid, Type B Plug |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $24.63 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $21.84 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $20.05 | 2024 | Arcalyst |
| Abiomed | $14.40 | 2023 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.